Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
$ 50.1 0.68%

Annual report 2025
added 03-02-2026

report update icon

Supernus Pharmaceuticals Operating Cycle 2011-2026 | SUPN

Annual Operating Cycle Supernus Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
492 387 461 457 418 341 665 702 470 582 611 904 2.53 K - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.53 K 341 694

Quarterly Operating Cycle Supernus Pharmaceuticals

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
438 332 388 - 420 446 519 - 488 487 447 - 379 469 533 - 382 283 394 - 289 627 933 79.3 582 677 749 81 648 730 669 67.7 424 464 597 60.8 66.7 73.4 69.6 54.1 60.1 66.3 68.5 50.5 70.2 57.1 113 44.6 367 1.64 K 1.57 K 21.4 251 - 28.1 139 - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.64 K 21.4 378

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
237 $ 21.87 2.15 % $ 1.02 B usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
245 - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
4.89 $ 0.94 5.23 % $ 6.91 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
332 $ 22.67 3.23 % $ 3.76 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
32 - -1.52 % $ 24.7 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
99.7 $ 2.02 5.5 % $ 420 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
842 $ 1.2 0.42 % $ 200 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
ImmuCell Corporation ImmuCell Corporation
ICCC
232 $ 8.24 -1.38 % $ 74.4 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
115 - 5.93 % $ 314 M canadaCanada
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
59 - 17.91 % $ 11.1 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
223 $ 4.17 2.21 % $ 446 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
291 $ 23.73 2.02 % $ 3.02 B usaUSA
Jaguar Health Jaguar Health
JAGX
964 $ 0.35 -9.42 % $ 816 K usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
129 $ 1.45 0.35 % $ 386 M britainBritain
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
213 $ 20.06 2.18 % $ 1.08 B britainBritain
AstraZeneca PLC AstraZeneca PLC
AZN
206 - - $ 96.9 B britainBritain
BioDelivery Sciences International BioDelivery Sciences International
BDSI
436 - -4.8 % $ 255 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Ligand Pharmaceuticals Incorporated Ligand Pharmaceuticals Incorporated
LGND
77.8 $ 233.96 1.16 % $ 4.28 B usaUSA